Skip to content

Clinical trials

Phase 2/3 trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Netherlands Clear all

314 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20016
20024
20034
200410
200510
200611
200714
200813
200911
20107
201111
201220
20136
201414
201516
201610
201712
201817
201911
202013
202112
202220
202317
202416
202515
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed135
Recruiting51
Terminated50
Unknown status42
Active, not recruiting24
Enrolling by invitation7
Withdrawn3
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Radboud University Medical Center19
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)11
Janssen Research & Development, LLC9
Bristol-Myers Squibb8
Novartis Pharmaceuticals8
The Netherlands Cancer Institute8
European Organisation for Research and Treatment of Cancer - EORTC7
Leiden University Medical Center7
Amsterdam UMC, location VUmc6
Boehringer Ingelheim6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease11
Colitis, Ulcerative10
Heart Failure9
Neoplasm Metastasis9
Coronary Artery Disease8
Carcinoma, Non-Small-Cell Lung7
Colorectal Neoplasms7
Breast Neoplasms6
Dementia6
Atherosclerosis5

Trials

Showing 76 to 100 of 314. Each trial links to its page on Pharma Observatory.

214 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.